# FAM13A

## Overview
FAM13A is a gene that encodes a protein known as family with sequence similarity 13 member A, which is involved in various cellular processes, particularly in the regulation of metabolic and respiratory functions. The protein belongs to the RhoGTPase activating protein (RhoGAP) family, which plays a critical role in inactivating GTPases, thereby influencing cellular dynamics and signaling pathways (Ruffin2019Twohybrid; Zhu2021Family). FAM13A is expressed in multiple tissues, including adipose tissue and lung epithelium, where it regulates processes such as adipogenesis, lipolysis, and epithelial-mesenchymal transition (EMT) (Lundbäck2018FAM13A; Chen2021A). Clinically, FAM13A is significant due to its association with chronic obstructive pulmonary disease (COPD) and metabolic disorders, with genetic variants linked to disease susceptibility and metabolic phenotypes (Zhu2021Family; Fathzadeh2020FAM13A).

## Function
FAM13A is a gene that encodes a protein involved in various cellular processes, including the regulation of adipocyte differentiation and function. In healthy human cells, FAM13A is expressed in adipose tissue and plays a role in regulating lipolysis and adipogenesis. Knockdown of FAM13A in human mesenchymal stem cells has been shown to increase lipolysis and the expression of genes associated with adipogenesis, such as PPARG and CEBPA, indicating that FAM13A may inhibit these processes (Lundbäck2018FAM13A). 

FAM13A is also involved in the regulation of insulin sensitivity and glucose metabolism. Variants in the FAM13A locus are associated with increased expression in subcutaneous adipose tissue and are linked to insulin resistance-related phenotypes, such as higher waist-to-hip ratio and fasting insulin levels (Fathzadeh2020FAM13A). In hepatic cells, FAM13A represses AMP-activated protein kinase (AMPK) activity, which is crucial for energy homeostasis, and influences hepatic glucose and lipid metabolism (Lin2020FAM13A). 

The protein is active in the cytoplasm and may interact with other proteins to influence cellular dynamics, including mitochondrial function and energy metabolism (Lin2020FAM13A). These activities suggest that FAM13A plays a significant role in maintaining metabolic homeostasis in the body.

## Clinical Significance
The FAM13A gene is clinically significant due to its association with various diseases, particularly chronic obstructive pulmonary disease (COPD) and metabolic disorders. Variants in FAM13A have been linked to increased susceptibility to COPD, with studies indicating that FAM13A expression is upregulated in the small airway epithelium of COPD patients, independent of smoking status. This upregulation is associated with epithelial-mesenchymal transition (EMT), a process involved in airway remodeling, and correlates with disease severity (Zhu2021Family). The gene's role in COPD is further supported by its involvement in TGF-β1-induced EMT, promoting cell proliferation and motility (Zhu2021Family).

In metabolic health, FAM13A variants are associated with insulin resistance-related traits, such as higher waist-to-hip ratio and fasting insulin levels. These variants influence adipose tissue distribution, contributing to a metabolically unhealthy phenotype despite normal weight (Fathzadeh2020FAM13A). FAM13A expression in subcutaneous adipose tissue is linked to unfavorable body fat distribution, potentially leading to a 'lipodystrophy-like' pattern (Fathzadeh2020FAM13A). The gene is also implicated in idiopathic pulmonary fibrosis (IPF), with specific SNPs like rs2609255 associated with increased IPF risk (GuzmánVargas2021Differential).

## Interactions
FAM13A is involved in various interactions with proteins and potentially nucleic acids, influencing cellular processes. The protein encoded by FAM13A contains a RhoGTPase activating protein (RhoGAP) domain, which is involved in inactivating GTPases by converting GTP to GDP, suggesting interactions with GTPases (Ruffin2019Twohybrid; Zhu2021Family). In the context of lung epithelial cells, FAM13A has been shown to interact functionally with proteins such as E-cadherin and β-catenin, which are crucial for maintaining epithelial barrier integrity. Overexpression of FAM13A enhances the expression of these junctional proteins, indicating a role in stabilizing cell-cell contacts (Chen2021A).

FAM13A is also implicated in the epithelial-mesenchymal transition (EMT) process, particularly in the context of chronic obstructive pulmonary disease (COPD). It is upregulated in response to TGF-β1, a known EMT inducer, and correlates with EMT markers such as E-cadherin and vimentin, suggesting indirect interactions through EMT pathways (Zhu2021Family). While specific physical interactions with nucleic acids are not detailed, FAM13A's involvement in gene expression regulation and cellular responses implies potential interactions at the nucleic acid level (Huang2022Integrating).


## References


[1. (Lin2020FAM13A) Xin Lin, Yae-Huei Liou, Yujun Li, Lu Gong, Yan Li, Yuan Hao, Betty Pham, Shuang Xu, Zhiqiang Jiang, Lijia Li, Yifan Peng, Dandi Qiao, Honghuang Lin, Pengda Liu, Wenyi Wei, Guo Zhang, Chih-Hao Lee, and Xiaobo Zhou. Fam13a represses ampk activity and regulates hepatic glucose and lipid metabolism. iScience, 23(3):100928, March 2020. URL: http://dx.doi.org/10.1016/j.isci.2020.100928, doi:10.1016/j.isci.2020.100928. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.isci.2020.100928)

[2. (Fathzadeh2020FAM13A) Mohsen Fathzadeh, Jiehan Li, Abhiram Rao, Naomi Cook, Indumathi Chennamsetty, Marcus Seldin, Xiang Zhou, Panjamaporn Sangwung, Michael J. Gloudemans, Mark Keller, Allan Attie, Jing Yang, Martin Wabitsch, Ivan Carcamo-Orive, Yuko Tada, Aldons J. Lusis, Myung Kyun Shin, Cliona M. Molony, Tracey McLaughlin, Gerald Reaven, Stephen B. Montgomery, Dermot Reilly, Thomas Quertermous, Erik Ingelsson, and Joshua W. Knowles. Fam13a affects body fat distribution and adipocyte function. Nature Communications, March 2020. URL: http://dx.doi.org/10.1038/s41467-020-15291-z, doi:10.1038/s41467-020-15291-z. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-15291-z)

[3. (Zhu2021Family) Jinyuan Zhu, Faxuan Wang, Xueyan Feng, Beibei Li, Liqiong Ma, and Jin Zhang. Family with sequence similarity 13 member a mediates tgf-β1-induced emt in small airway epithelium of patients with chronic obstructive pulmonary disease. Respiratory Research, July 2021. URL: http://dx.doi.org/10.1186/s12931-021-01783-z, doi:10.1186/s12931-021-01783-z. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12931-021-01783-z)

[4. (GuzmánVargas2021Differential) Javier Guzmán-Vargas, Enrique Ambrocio-Ortiz, Gloria Pérez-Rubio, Marco Antonio Ponce-Gallegos, Rafael de Jesus Hernández-Zenteno, Mayra Mejía, Alejandra Ramírez-Venegas, Ivette Buendia-Roldan, and Ramcés Falfán-Valencia. Differential genomic profile in tert, dsp, and fam13a between copd patients with emphysema, ipf, and cpfe syndrome. Frontiers in Medicine, August 2021. URL: http://dx.doi.org/10.3389/fmed.2021.725144, doi:10.3389/fmed.2021.725144. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmed.2021.725144)

[5. (Lundbäck2018FAM13A) Veroniqa Lundbäck, Agne Kulyte, Rona J. Strawbridge, Mikael Ryden, Peter Arner, Claude Marcus, and Ingrid Dahlman. Fam13a and pom121c are candidate genes for fasting insulin: functional follow-up analysis of a genome-wide association study. Diabetologia, 61(5):1112–1123, February 2018. URL: http://dx.doi.org/10.1007/s00125-018-4572-8, doi:10.1007/s00125-018-4572-8. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-018-4572-8)

[6. (Huang2022Integrating) Hai-Hui Huang and Yong Liang. Integrating molecular interactions and gene expression to identify biomarkers and network modules of chronic obstructive pulmonary disease. Technology and Health Care, 30:135–142, February 2022. URL: http://dx.doi.org/10.3233/thc-228013, doi:10.3233/thc-228013. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3233/thc-228013)

[7. (Ruffin2019Twohybrid) Manon Ruffin, Kristin E. Thompson, Harriet Corvol, and Loic Guillot. Two-hybrid screening of fam13a protein partners in lung epithelial cells. BMC Research Notes, December 2019. URL: http://dx.doi.org/10.1186/s13104-019-4840-9, doi:10.1186/s13104-019-4840-9. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13104-019-4840-9)

[8. (Chen2021A) Qing Chen, Maaike de Vries, Kingsley Okechukwu Nwozor, Jacobien A. Noordhoek, Corry-Anke Brandsma, H. Marike Boezen, and Irene H. Heijink. A protective role of fam13a in human airway epithelial cells upon exposure to cigarette smoke extract. Frontiers in Physiology, June 2021. URL: http://dx.doi.org/10.3389/fphys.2021.690936, doi:10.3389/fphys.2021.690936. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2021.690936)